These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19651907)

  • 1. Identification of inhibitors of yellow fever virus replication using a replicon-based high-throughput assay.
    Patkar CG; Larsen M; Owston M; Smith JL; Kuhn RJ
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4103-14. PubMed ID: 19651907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of Vero cell lines persistently harboring a yellow fever virus 17D subgenomic replicon.
    Saito K; Shimasaki K; Fukasawa M; Suzuki R; Okemoto-Nakamura Y; Katoh K; Takasaki T; Hanada K
    Virus Res; 2022 Dec; 322():198935. PubMed ID: 36152929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus.
    Gao Z; Zhang L; Ma J; Jurado A; Hong SH; Guo JT; Rice CM; MacDonald MR; Chang J
    Antiviral Res; 2020 Oct; 182():104907. PubMed ID: 32798604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a reporter yellow fever virus for high throughput antiviral assays.
    Sanchez-Velazquez R; de Lorenzo G; Tandavanitj R; Setthapramote C; Bredenbeek PJ; Bozzacco L; MacDonald MR; Clark JJ; Rice CM; Patel AH; Kohl A; Varjak M
    Antiviral Res; 2020 Nov; 183():104939. PubMed ID: 32980446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specialized
    Li D; Lu HT; Ding YZ; Wang HJ; Ye JL; Qin CF; Liu ZY
    J Virol; 2023 Apr; 97(4):e0194922. PubMed ID: 37017533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A yellow fever virus NS4B inhibitor not only suppresses viral replication, but also enhances the virus activation of RIG-I-like receptor-mediated innate immune response.
    Gao Z; Zhang X; Zhang L; Wu S; Ma J; Wang F; Zhou Y; Dai X; Bullitt E; Du Y; Guo JT; Chang J
    PLoS Pathog; 2022 Jan; 18(1):e1010271. PubMed ID: 35061864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen.
    Gu B; Ouzunov S; Wang L; Mason P; Bourne N; Cuconati A; Block TM
    Antiviral Res; 2006 Jun; 70(2):39-50. PubMed ID: 16724398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery.
    Puig-Basagoiti F; Deas TS; Ren P; Tilgner M; Ferguson DM; Shi PY
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4980-8. PubMed ID: 16304161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
    De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
    Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation.
    Fioravanti R; Desideri N; Carta A; Atzori EM; Delogu I; Collu G; Loddo R
    Eur J Med Chem; 2017 Dec; 141():15-25. PubMed ID: 29028528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
    Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T
    Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and applications of yellow fever virus replicons.
    Jones CT; Patkar CG; Kuhn RJ
    Virology; 2005 Jan; 331(2):247-59. PubMed ID: 15629769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
    Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
    Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential high-throughput assay for screening inhibitors of West Nile virus replication.
    Lo MK; Tilgner M; Shi PY
    J Virol; 2003 Dec; 77(23):12901-6. PubMed ID: 14610212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure.
    Mendes ÉA; Pilger DRB; Santos Nastri ACS; Malta FM; Pascoalino BDS; Carneiro D'Albuquerque LA; Balan A; Freitas LHG; Durigon EL; Carrilho FJ; Rebello Pinho JR
    Ann Hepatol; 2019; 18(6):816-824. PubMed ID: 31594756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon Particles.
    Lücke AC; Vom Hemdt A; Wieseler J; Fischer C; Feldmann M; Rothenfusser S; Drexler JF; Kümmerer BM
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo.
    Qian X; Wu B; Tang H; Luo Z; Xu Z; Ouyang S; Li X; Xie J; Yi Z; Leng Q; Liu Y; Qi Z; Zhao P
    Emerg Microbes Infect; 2022 Dec; 11(1):873-884. PubMed ID: 35249454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and Application of Flavivirus Replicons.
    Kümmerer BM
    Adv Exp Med Biol; 2018; 1062():165-173. PubMed ID: 29845532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro.
    Kaptein SJ; De Burghgraeve T; Froeyen M; Pastorino B; Alen MM; Mondotte JA; Herdewijn P; Jacobs M; de Lamballerie X; Schols D; Gamarnik AV; Sztaricskai F; Neyts J
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5269-80. PubMed ID: 20837762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.
    Hao W; Herlihy KJ; Zhang NJ; Fuhrman SA; Doan C; Patick AK; Duggal R
    Antimicrob Agents Chemother; 2007 Jan; 51(1):95-102. PubMed ID: 17060518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.